MedWatch

Demant won major market shares at VA in May

In May, the hearing aid company company Demant advanced in the public US sales channel Veterans Affairs, while GN Hearing retreated for the sixth month in a row.

Demant CEO Søren Nielsen | Photo: Kenneth Lysbjerg Koustrup/ERH

Demant won major market shares in hearing aids in the public US sales channel Veterans Affairs (VA) in May, as the firm's top product Oticon More was included in the VA contract as of May. GN Hearing only retreated a little, according to the most recent monthly report from VA.

For GN Hearing, this is the sixth month in a row that the firm retreated, as its market share dropped to 8.87 percent in May from 10.27 percent in April.

Read the whole article

Get 14 days free access.
No credit card required.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Pfizer upgrades guidance for sales of covid-19 vaccine

The US pharmaceutical company Pfizer now predicts sales of its coronavirus vaccines will total USD 33.5bn this year. The previous estimate was UDS 26bn. Meanwhile, the company has revealed the guidance for its annual revenue.

Further reading

Related articles

Trial banner

Latest news

See all jobs